首尔大学、KAIST、延世大学等韩国QS前10名大学的研究室信息。
Professor Hyung-Gi Kim's research lab specializes in cancer biology, with a primary focus on cancer stem cells (CSCs), particularly glioblastoma stem cells (GSCs) and glioma-initiating cells (GICs). The lab investigates the molecular mechanisms governing CSC self-renewal, tumorigenesis, therapy resistance, and the tumor microenvironment—especially the crosstalk between cancer stem cells and endothelial cells. Key signaling pathways such as NOTCH, PDGF/NO/ID4, and TERT-mediated survival mechanisms are central to their work, aiming to uncover novel therapeutic targets for aggressive brain tumors.
Professor Ji Hoon Phi's research lab specializes in pediatric and adult neuro-oncology, with a focus on brain tumors, cerebrovascular disorders, and neurogenetic syndromes. The lab investigates the molecular and cellular mechanisms underlying intracranial germ cell tumors, medulloblastoma subgroups, and moyamoya disease, particularly in the context of systemic conditions like neurofibromatosis and Down syndrome. A central theme is the role of key transcription factors such as Sox2 in tumor stemness and the tumor microenvironment, including tumor-associated macrophages. The lab also explores image-guided radiosurgery and surgical outcomes in rare intracranial pathologies such as vestibular schwannomas and sacrococcygeal teratomas.
Professor Bu Kyung Han's research lab specializes in diagnostic radiology and medical imaging, with a focus on improving the accuracy of cancer detection and characterization using advanced imaging modalities such as MRI, ultrasound, and nuclear medicine. The lab investigates the diagnostic performance of imaging techniques in breast cancer, thyroid cancer recurrence, and musculoskeletal disorders, emphasizing the correlation between imaging findings, histopathology, and clinical outcomes. A key research direction involves refining the interpretation of complex imaging patterns to reduce false positives and improve patient management in oncology and inflammatory diseases.
Professor Ki Yong Lee's research lab specializes in the discovery and preclinical evaluation of bioactive natural compounds from medicinal plants, with a focus on neuroprotection, anti-cancer, and anti-inflammatory properties. The lab investigates natural products such as phenylethanoid glycosides, triterpenes, flavonoids, and diterpenes for their therapeutic potential in neurological disorders, stroke, and cancer metastasis. Key research directions include elucidating molecular mechanisms of action, pharmacokinetic profiling, and structure-activity relationships of plant-derived compounds.
Professor Yeo Joon Yoon's research lab specializes in microbial natural product discovery and biosynthesis, with a focus on understanding the genetic and enzymatic mechanisms underlying the production of bioactive secondary metabolites in actinomycetes and other microorganisms. The lab integrates synthetic biology, metabolic engineering, and advanced analytical technologies—such as LC-ESI-MS/MS and metabolomics—to enable the sustainable production of pharmaceuticals, antibiotics, and other high-value compounds. Key research directions include the heterologous expression of plant biosynthetic pathways in microbes, the engineering of polyketide and nonribosomal peptide synthetases, and the development of high-throughput methods for metabolite profiling and pathway characterization.
Professor Dongjin Lee's research lab specializes in advanced functional materials and nanofabrication for next-generation electronic and biomedical applications. The lab focuses on developing flexible and transparent conductors using silver nanowires and conducting polymers, with applications in wearable electronics and touch panels. It also pioneers microfluidic fabrication of 3D cell culture systems for tumor spheroid modeling and designs nanostructured sensors—particularly based on carbon nanotubes and enzyme-functionalized multilayers—for highly sensitive, conductometric detection of biomolecules like glucose. The lab emphasizes scalable, low-temperature manufacturing processes such as roll-to-roll coating and layer-by-layer assembly to enable practical integration of nanomaterials into real-world devices.
Professor Sung-jin Hong's research lab specializes in interventional cardiology and preventive cardiology, with a primary focus on optimizing antiplatelet and lipid-lowering therapies in patients with acute coronary syndrome and atherosclerotic cardiovascular disease. The lab investigates strategies for shortening dual antiplatelet therapy duration after drug-eluting stent implantation, evaluates the efficacy and safety of high-intensity versus treat-to-target statin therapy, and explores novel approaches to improving stent technology and vascular function. Their work is grounded in large-scale, multicenter clinical trials that aim to enhance patient outcomes while minimizing bleeding and adverse effects.
Professor Ijin Joo's research lab specializes in advanced medical imaging techniques for the diagnosis, staging, and treatment monitoring of hepatobiliary and pancreatic malignancies. The lab focuses on optimizing multimodality and multiparametric imaging strategies—particularly gadoxetic acid-enhanced MRI, diffusion-weighted imaging (DWI), and PET/MRI—to improve the accuracy of tumor characterization and preoperative assessment. Key research directions include the development of quantitative imaging biomarkers for early response prediction and the integration of advanced radiological protocols into clinical guidelines for liver and pancreatic cancers.
Professor Lee Bong Jae's research lab specializes in nanophotonic thermal management, focusing on the design and engineering of advanced materials and structures for enhanced thermal radiation control. The lab explores coherent thermal emission, surface polaritons (plasmon and phonon), and near-field radiative heat transfer using nanostructured materials such as multilayer films, metallic gratings, and dielectric/metallo-dielectric heterostructures. Key research directions include radiative cooling, broadband solar absorption, and directional thermal emission for energy-efficient applications.
Professor Jeong Byung-chang's research lab focuses on translational urological oncology, with a strong emphasis on understanding tumor heterogeneity and treatment resistance in bladder cancer through single-cell genomics and patient-derived xenograft models. The lab investigates the tumor microenvironment and cancer evolution to develop personalized therapeutic strategies, particularly for aggressive, chemotherapy-resistant urothelial carcinomas. Additionally, the lab explores minimally invasive surgical techniques and the role of natural compounds like green tea in urological diseases, including stone formation and cancer prevention.
Professor Han Sang Yoo's research lab specializes in veterinary virology, bacteriology, and molecular diagnostics, with a strong focus on zoonotic pathogens such as hepatitis E virus (HEV), Clostridium perfringens, and SARS-CoV-2. The lab develops molecular detection methods—including multiplex and nested RT-PCR—for rapid and accurate identification of infectious agents in livestock and humans, particularly in the context of emerging and re-emerging diseases. A key research direction involves understanding host-pathogen interactions, including cytokine responses in bovine immune cells, and evaluating mucosal vaccine delivery systems using nanoparticle-based platforms to enhance immune protection. The lab also contributes to the surveillance and molecular characterization of zoonotic viruses in animal reservoirs, supporting 'One Health' approaches to pandemic preparedness and zoonotic disease control.
Professor Jaeyeong Kim's research lab specializes in developing advanced biomedical technologies that bridge artificial intelligence, molecular engineering, and clinical diagnostics. The lab focuses on creating deep learning-based diagnostic systems for medical imaging—particularly in dentistry and orthopedics—while also pioneering innovative protein engineering platforms for antibody purification and immunoassays. Their work emphasizes clinical translation, integrating machine learning with biological specificity to improve disease detection and therapeutic development.
Professor Hyungjin Kim's research lab specializes in neuromorphic computing and advanced memory technologies, focusing on developing hardware-efficient, brain-inspired computing systems. The lab explores scalable memristive crossbar circuits, synaptic transistors with dual-gate structures, and spiking neural network (SNN) implementations for low-power, high-efficiency AI workloads. Key research directions include device-level optimization for variability and noise resilience, hardware-software co-design for neural network deployment, and the integration of encryption with data compression in emerging computing architectures. The lab also investigates 3D NAND flash memory technologies and their role in next-generation nonvolatile storage and neuromorphic systems.
Professor Jinmo Kim's research lab specializes in human-centered immersive technologies, focusing on enhancing user experience in virtual reality (VR) through innovative haptic, motion, and gaze-based interaction systems. The lab develops low-cost, wearable haptic devices and intuitive input methods—such as cane-based navigation for the visually impaired and hand-motion tracking using consumer sensors—to improve immersion and reduce VR-induced discomfort. Additionally, the lab explores advanced materials for energy applications, particularly graphene quantum dots in dye-sensitized solar cells and surface characterization techniques for functional thin films. These interdisciplinary efforts bridge human-computer interaction, biomedical engineering, and materials science to create accessible, realistic, and efficient VR and energy technologies.
Professor Hong Hee Kim's research lab focuses on the intersection of nanomaterials and biological systems, with a strong emphasis on colloidal quantum dots for optoelectronic applications and the molecular mechanisms of cellular signaling in bone and immune cells. The lab investigates charge transport optimization in quantum dot-based light-emitting devices and explores the role of reactive oxygen species, RANK/RANKL signaling, and chemokines like CXCL2 in osteoclastogenesis and endothelial cell survival. Key research directions include nanomaterial engineering for next-generation displays and solid-state lighting, as well as signal transduction pathways in immune and bone cells.
Professor Junghoon Kim's research lab specializes in the development of advanced functional materials for next-generation electronic and energy applications, with a focus on flexible and stretchable electronics, smart hydrogels, and high-performance ceramic membranes. The lab pioneers innovative nanocomposite and block copolymer systems to achieve tunable porosity, enhanced mechanical resilience, and multifunctionality—critical for wearable sensors, solid-state batteries, and efficient solar cells. By integrating materials design with scalable fabrication techniques such as plasma treatment and nanopatterning, the lab addresses key challenges in stability, sensitivity, and processability.
Professor Joo-Hoon Kang's research lab specializes in the development and characterization of two-dimensional (2D) nanomaterials, with a focus on black phosphorus and perovskite-based materials for optoelectronic and electronic applications. The lab pioneers scalable, low-degradation synthesis methods—such as surfactant-assisted exfoliation in deoxygenated water and microfluidic-based cell separation techniques—to enable high-quality, electronic-grade 2D materials and advanced biomedical diagnostics. Key research directions include understanding defect physics in organic semiconductors like pentacene and engineering high-color-purity 2D perovskite LEDs for next-generation displays and lighting.
Professor Yejin Kim's research lab specializes in biomedical and health informatics, focusing on computational phenotyping, personalized health prediction, and the biological mechanisms underlying chronic diseases and behavioral disorders. The lab develops advanced data-driven methodologies—such as federated tensor factorization and machine learning models—to extract meaningful clinical insights from electronic health records while preserving patient privacy. It also investigates the role of micronutrients (e.g., vitamin C) and natural compounds (e.g., β-sitosterol) in modulating inflammatory and viral responses, aiming to bridge molecular mechanisms with clinical outcomes. Additionally, the lab explores behavioral health factors, including smartphone addiction, through integrative analysis of psychological, demographic, and usage pattern data.
Professor Minjeong Kim's research lab focuses on molecular mechanisms underlying cancer progression, with a particular emphasis on autophagy in oncogenic transformation, especially in K-Ras-driven malignancies. The lab also investigates fungal pathogenesis, particularly the role of zinc homeostasis and transcription factors like Csr1 in Candida albicans filamentation and virulence. In addition, the lab conducts clinical and health services research, analyzing surgical outcomes and cost-effectiveness in spinal disorders under national health insurance systems. A growing focus is on the biological and neurochemical links between metabolic disease and mental health, using preclinical models to explore biomarkers for obesity-associated mood disorders.
Professor Hwang Jin-Hyeok's research lab focuses on gastrointestinal oncology and molecular pathology, with a primary emphasis on pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (biliary tract cancer). The lab investigates molecular biomarkers—such as miR-21, CD24, S100A4, and PD-L1—that predict disease progression, treatment response, and prognosis. It also explores inflammatory mediators like IL-6 and IL-8, and the role of immune checkpoint inhibitors in advanced biliary tract cancers. Additionally, the lab contributes to clinical diagnostics, including improved criteria for autoimmune pancreatitis and the impact of gastric atrophy on H. pylori detection. Overall, the lab bridges molecular oncology with translational clinical research to improve personalized therapy in gastrointestinal malignancies.
